This approach represents a fundamental shift from the conventional more is better mentality in medicine
doi: 10.1016/j.bbr.2017.11.015 [DOI] [PubMed] [Google Scholar] 119.Mayneris-Perxachs J, Castells-Nobau A, Arnoriaga-Rodrguez M, et al
" Foundayo marks a significant advancement in obesity treatment by providing patients with a convenient daily pill option instead of weekly injections ." FDA Approval Statement, 2026 What Makes Orforglipron Different From Earlier Pills Like other GLP-1 drugs, Foundayo mimics the hormone that controls appetite, digestion, and insulin
The evidence suggests the shedding is related to the metabolic stress of rapid weight loss
Short answer Compare cash pay vs insurance costs for GLP-1 medications like semaglutide
It comes down to what fits your life